Kowsar Mohamud, | |
14715 Ne Bel Red Rd Ste 104, Bellevue, WA 98007-3940 | |
(425) 502-9440 | |
Not Available |
Full Name | Kowsar Mohamud |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 14715 Ne Bel Red Rd Ste 104, Bellevue, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366121121 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 491431 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kowsar Mohamud, 3026 S Brighton St, Seattle, WA 98108-3777 Ph: () - | Kowsar Mohamud, 14715 Ne Bel Red Rd Ste 104, Bellevue, WA 98007-3940 Ph: (425) 502-9440 |
News Archive
QLT Inc. today announced that QLT091001, the Company's oral synthetic retinoid, has been granted orphan drug designation for the treatment of Retinitis Pigmentosa (RP) from the U.S. Food and Drug Administration (FDA). This follows the FDA grant of orphan drug designation for QLT091001 for the treatment of Leber Congenital Amaurosis (LCA) also on December 7, 2010.
A first-time finding of intraocular pressure increases in patients with no personal or family history of glaucoma following anti-VEGF treatment for wet age-related macular degeneration (AMD), and a report on a simple, low-cost method that could revolutionize vision screening and treatment in developing countries, are highlights of today's Scientific Program of the 2009 Joint Meeting of the American Academy of Ophthalmology (AAO) and the Pan-American Association of Ophthalmology (PAAO).
California Poison Control System is observing National Lead Poisoning Prevention Week and warns consumers that lead can be found in a variety of products available to children.
Positron emission tomography plays a pivotal role for monitoring the distribution and accumulation of radiolabeled nanomaterials in living subjects. The radioactive metals are usually connected to the nanomaterial through an anchor, a so-called chelator, but this chemical binding can be omitted if nanographene is used, as American scientists report in the journal Angewandte Chemie
People with a history of stroke or diabetes who were given clot-busting drugs to break up blood clots after stroke fared better than those who did not receive the drugs, according to a study published in the November 16, 2011, online issue of Neurology, the medical journal of the American Academy of Neurology.
› Verified 8 days ago
Kimberly Lum, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 16411 Ne 24th St, Bellevue, WA 98008 Phone: 425-456-5787 | |
Teresa Suhrbier, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 13010 Ne 20th St Ste 300, Bellevue, WA 98005 Phone: 425-644-6328 | |
Kristin M. Henkes, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 16120 Ne 8th St, Bellevue, WA 98008 Phone: 425-747-4004 Fax: 425-747-1069 | |
Ms. Brooke Eytchison, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2800 Northup Way # 260, Bellevue, WA 98004 Phone: 425-827-5877 | |
Jessica Seminary, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2515 140th Ave Ne Ste E110, Bellevue, WA 98005 Phone: 425-644-4100 | |
Shu-min Lin, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 919 109th Ave Ne, Bellevue, WA 98004 Phone: 425-531-7084 | |
Laura Jo Flanigan, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 Fax: 844-620-1839 |